The Spore Report

Legal

Decriminalization, regulation, and access — where psilocybin stands under the law, who is changing it, and what it means for the path ahead.

Weekly Digest

Never Miss What Matters

One weekly email. The best psilocybin research, podcasts, and news from trusted sources around the world — no searching required.

Pennsylvania psilocybin therapy bill: Psilocybin for Mental Health: Pa. Legislature Weighs Access
Legal

Psilocybin for Mental Health: Pa. Legislature Weighs Access

In September 2025, Pennsylvania House Democrats convened a policy committee hearing on a bipartisan bill that would legalize psilocybin therapy in the state, but only after federal FDA…

Minnesota psilocybin research bill: Minnesota Psilocybin Research Bill: What Lawmakers Approved
Legal

Minnesota Psilocybin Research Bill: What Lawmakers Approved

Minnesota state lawmakers are on the verge of approving legislation that would authorize federally funded psilocybin research. The bill does not legalize psilocybin for general use. It is…

Senate Bill S.4031 psychedelic research: Senate Bill S.4031: Federal Psychedelic Research at the VA
Legal

Senate Bill S.4031: Federal Psychedelic Research at the VA

Senate Bill S.4031, the Innovative Therapies Centers of Excellence Act, would authorize the Department of Veterans Affairs to establish specialized centers studying psilocybin, MDMA, ibogaine, ketamine, and 5-MeO-DMT…

Psilocybin access bill Congress: Psilocybin Access: Bipartisan Bill Targets Seriously Ill Patients
Legal

Psilocybin Access: Bipartisan Bill Targets Seriously Ill Patients

A bipartisan bill introduced in Congress would permit licensed physicians to administer Schedule I controlled substances, including psilocybin and MDMA, to patients with serious or terminal illnesses. The…

FDA psychedelic drug research: FDA Fast-Tracks Psychedelic Research: What the Order Means
Legal

FDA Fast-Tracks Psychedelic Research: What the Order Means

The FDA announced a package of measures designed to speed up clinical research into psychedelic-based treatments for serious conditions including treatment-resistant depression, PTSD, and substance use disorders. The…

FDA REMS framework psilocybin: FDA REMS Framework and Psilocybin Therapy Access - The Church of Psychedelics
Legal

FDA REMS Framework and Psilocybin Therapy Access

A legal analysis published by Vicente LLP examines the federal pathway through which psychedelic medicines such as COMP360, a proprietary psilocybin formulation, could reach clinical use under FDA…

The Spore Report · Weekly

You've Come This Far. Stay Informed.

Join our free weekly newsletter and get the best psilocybin research, medical journals, podcasts, and news — hand-curated from trusted sources around the world and delivered straight to your inbox.